Literature DB >> 16537118

High-risk pregnancies in Diamond-Blackfan anemia: a survey of 64 pregnancies from the French and German registries.

Laurence Faivre1, Jörg Meerpohl, Lydie Da Costa, Isabelle Marie, Christian Nouvel, Astrid Gnekow, Christine Bender-Götze, Francis Bauters, Bertand Coiffier, Pierre-Yves Peaud, Patrick Rispal, Alain Berrebi, Claire Berger, Michel Flesch, Paul Sagot, Bruno Varet, Charlotte Niemeyer, Gil Tchernia, Thierry Leblanc.   

Abstract

We reviewed 64 pregnancies in 26 women with Diamond-Blackfan anemia (DBA) included in the French and German DBA registries. Complications were seen in 42 pregnancies (66%) and included abortion, pre-eclampsia, in utero fetal death, intrauterine growth retardation, retroplacental hematoma, pre-term delivery and fetal malformations. Of the 34 children (53%) born alive, 13 had DBA. No correlations were found between pregnancy outcome and features of either maternal or child DBA. Pregnancies in DBA-affected women are at high risk, especially for complications likely to be of vascular-placental origin. Careful monitoring with prevention of severe anemia and early introduction of aspirin is suggested.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16537118

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  16 in total

Review 1.  Anemia of Central Origin.

Authors:  Kazusa Ishii; Neal S Young
Journal:  Semin Hematol       Date:  2015-07-09       Impact factor: 3.851

2.  Pregnancy outcomes in mothers of offspring with inherited bone marrow failure syndromes.

Authors:  Neelam Giri; Helen D Reed; Pamela Stratton; Sharon A Savage; Blanche P Alter
Journal:  Pediatr Blood Cancer       Date:  2017-08-12       Impact factor: 3.167

3.  Pregnancy outcomes in inherited bone marrow failure syndromes.

Authors:  John M Gansner; Maureen M Achebe; Kathryn J Gray; Revital Yefidoff-Freedman; Elena Labovitis; Aric Parnes; Jean M Connors; Nathan T Connell; Marie N Discenza; Robert I Handin; Nancy Berliner; Akiko Shimamura; Elizabeth S Ginsburg; Nicole A Smith
Journal:  Blood       Date:  2017-08-10       Impact factor: 22.113

4.  Reduced serum levels of anti-Müllerian hormone in females with inherited bone marrow failure syndromes.

Authors:  Martha M Sklavos; Pamela Stratton; Neelam Giri; Blanche P Alter; Sharon A Savage; Ligia A Pinto
Journal:  J Clin Endocrinol Metab       Date:  2014-11-18       Impact factor: 5.958

5.  Pregnancies in patients with inherited bone marrow failure syndromes in the NCI cohort.

Authors:  Neelam Giri; Pamela Stratton; Sharon A Savage; Blanche P Alter
Journal:  Blood       Date:  2017-08-24       Impact factor: 22.113

6.  Genetic predisposition to MDS: diagnosis and management.

Authors:  Elissa Furutani; Akiko Shimamura
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

Review 7.  How I treat Diamond-Blackfan anemia.

Authors:  Adrianna Vlachos; Ellen Muir
Journal:  Blood       Date:  2010-07-22       Impact factor: 22.113

8.  Diamond-Blackfan anemia, ribosome and erythropoiesis.

Authors:  L Da Costa; H Moniz; M Simansour; G Tchernia; N Mohandas; T Leblanc
Journal:  Transfus Clin Biol       Date:  2010-07-23       Impact factor: 1.406

Review 9.  Inherited bone marrow failure syndromes in adolescents and young adults.

Authors:  David B Wilson; Daniel C Link; Philip J Mason; Monica Bessler
Journal:  Ann Med       Date:  2014-06-03       Impact factor: 4.709

10.  The ribosomal basis of Diamond-Blackfan Anemia: mutation and database update.

Authors:  Ilenia Boria; Emanuela Garelli; Hanna T Gazda; Anna Aspesi; Paola Quarello; Elisa Pavesi; Daniela Ferrante; Joerg J Meerpohl; Mutlu Kartal; Lydie Da Costa; Alexis Proust; Thierry Leblanc; Maud Simansour; Niklas Dahl; Anne-Sophie Fröjmark; Dagmar Pospisilova; Radek Cmejla; Alan H Beggs; Mee R Sheen; Michael Landowski; Christopher M Buros; Catherine M Clinton; Lori J Dobson; Adrianna Vlachos; Eva Atsidaftos; Jeffrey M Lipton; Steven R Ellis; Ugo Ramenghi; Irma Dianzani
Journal:  Hum Mutat       Date:  2010-12       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.